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Abstract
OBJECTIVES: Small-sized aortic bioprostheses may cause high postoperative gradients. In clinical practice, it is difﬁcult to compare bio-
prostheses from different manufactures, owing to the discrepancy between the true size and the nominal size of the prosthesis and the
inter-patient variability in aortic root characteristics. In vitro studies provide accurate data, and using a system in which it is possible to
implant bioprostheses in a true aortic root should enable a fair comparison to be made. The present study compared the four most widely
used pericardial stented bioprostheses from different manufacturers surgically implanted in small annulus, to detect any differences in
their ﬂuid-dynamic performance.
METHODS: The four types of bioprostheses, each implanted in a randomized sequence in eight porcine aortic roots, with a native annulus
of 2.1 cm, were tested in a mock loop at 65 ml of stroke volume by calculating hydrodynamic parameters, namely mean pressure drop
and effective oriﬁce area, performance index, valve resistance and % of energy loss. The prostheses that ﬁtted the aortic root after sizing
were as follows: a Magna Ease 21, a Trifecta 21, a Soprano-Armonia 20 and a Mitroﬂow 23.
RESULTS: Effective oriﬁce areas were 1.57 ± 0.2, 1.77 ± 0.2, 2.3 ± 0.3 and 1.75 ± 0.2 cm2 (P < 0.001) for Magna Ease, Mitroﬂow, Trifecta and
Soprano-Armonia, respectively. The mean gradients were 13.2 ± 3, 10.2 ± 3, 6.1 ± 2 and 9.6 ± 2 mmHg (P < 0.001) for Magna Ease,
Mitroﬂow, Trifecta and Soprano-Armonia, respectively. The performance indices were 0.50 ± 0.06, 0.63 ± 0.08, 0.89 ± 0.13 and 0.56 ± 0.07
(P < 0.001) for Magna Ease, Mitroﬂow, Trifecta and Soprano-Armonia, respectively. The valve resistance, expressed in (dyn*s/cm5), was
69 ± 16, 55 ± 13, 33 ± 10 and 51 ± 11 (P < 0.001) for Magna Ease, Mitroﬂow, Trifecta and Soprano-Armonia, respectively. The percent of
energy loss was 13.5 ± 0.5, 10.7 ± 2.5, 6.6 ± 1.6, 10.9 ± 1.8 (P < 0.001) for Magna Ease, Mitroﬂow, Trifecta and Soprano-Armonia, respectively.
CONCLUSION: Our study combined the ﬂuid-dynamic reproducibility of the in vitro study with, by using porcine aortic roots, the speciﬁcity
of surgery. The results conﬁrmed that bioprostheses are inherently obstructive compared with the native aortic valve and showed that bio-
prostheses with the pericardium outside the stent are more efﬁcient.
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INTRODUCTION
After aortic valve replacement, some degree of residual gradient
persists, especially when small prostheses are implanted [1, 2]; this
may negatively inﬂuence patients’ survival and quality of life [3–5].
Because stented prostheses are inherently obstructive, the use of both
stentless valves and annulus enlargement has been proposed in order
to implant a prosthesis that ﬁts the patient’s haemodynamic require-
ments; so far, however, these two approaches have shown negligible
clinical effects [6, 7]. Pericardial bioprostheses, which are currently
widely used, have excellent durability and perform better than
porcine prostheses, especially in small aortic roots [8, 9].
Several types of pericardial prosthesis are currently available.
These differ in design, and, except for the Soprano-Armonia (SA)
from the Sorin group, all are sized according to a series of odd
numbers from 19 to 29. Moreover, prostheses with the same
labelled size from different manufacturers differ in terms of intern-
al diameter (ID), tissue annulus diameter (TAD) and external dia-
meter (ED) [10]. The heterogeneity of the true dimensions of
prostheses and the variability in patients’ aortic root anatomy in-
ﬂuence the size of the prosthesis to be implanted; it is therefore
difﬁcult to make a fair comparison of the haemodynamic perform-
ance of the various prostheses in the clinical setting. Indeed, even
a prosthesis of the same size made by the same manufacturer
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may not ﬁt in two patients with the same native aortic annulus
dimensions [11].
To evaluate the ﬂuid-dynamic behaviour of bioprostheses, the
in vitro setting is the ‘gold standard’, as it allows the device to be
studied thoroughly, that is, in systolic and diastolic phases, in a
very simpliﬁed environment with a high level of accuracy. In an
attempt to make a fair comparison, Gerosa et al. [12] set-up an in-
vestigational study in which they inserted prostheses of different
labelled sizes that ﬁtted the 21-mm ﬁrst mounting ring. However,
a prosthesis needs to be implanted and sutured in an aortic root
that has its own speciﬁc characteristics, which may inﬂuence
the haemodynamic result [13]. Thus, to eliminate the effect of
the speciﬁc aortic root characteristics, different prostheses should
be implanted in the same aortic root. Recently, an in vitro ap-
proach has been developed, which uses mock loop devices
with an aortic root inserted in the circuit, in order to recreate real-
istic haemodynamic conditions in the laboratory [14–16]. The
aim of the present study was to evaluate any differences in the
ﬂuid-dynamic performance of the four most widely used stented
pericardial bioprostheses, namely, Magna Ease (MG) (Edwards
Lifescience), Trifecta (TRI) (St. Jude Medical), Mitroﬂow (MF) and
Soprano-Armonia (Sorin group). To make a fair comparison, we
studied those labelled sizes that ﬁtted porcine aortic roots with a
native aortic annulus of 2.1 cm in diameter.
MATERIALS ANDMETHODS
FoRCardioLab pulsatile mock loop
Figure 1A shows a schematic representation of the mock loop
[14–16], which consisted of a computer-controlled volumetric
pump able to replicate left ventricular ﬂow waveforms, a sample
test section designed to house a whole aortic root and an adjust-
able hydraulic afterload mimicking the hydraulic input impedance
of the systemic circulation. For this experimental campaign, the
mock loop was instrumented with a transit-time ﬂow-meter
(HT100R, Transonic System, Inc., Ithaca, NY, USA), the 1’ probe of
which was placed downstream of the aortic root unit sample, and
with three pressure transducers (PC140 series, Honeywell, Inc.,
Morristown, NJ, USA): one immediately upstream and one imme-
diately downstream of the sample (Pven and Pao, respectively, in
Fig. 1), and the third placed at the inlet section of the hydraulic
afterload part. A high-speed digital camera (Phantom Miro2,
Visionresearch, Morristown, NJ, USA) was placed downstream of
the sample so as to acquire an aortic view of the working pros-
theses. Data were acquired at 200 Hz via an A/D board (USB 6210,
National Instrument, Austin, TX, USA).
Sample preparation and prosthesis sizing
In order to replicate the operating theatre scenario, the strategy
adopted was to choose the prosthesis size of each valve under
guidance by the probes and the valve replica for each brand, in
order to implant a valve that would ﬁt the annulus. Eight fresh
whole swine hearts were selected with a native aortic annulus of
2.1 cm, as measured by a metric probe. Prosthesis sizing was then
performed by using the probes provided by the manufacturer of
each prosthesis on the eight whole porcine hearts, in order to
select a prosthesis that could be comfortably implanted, with only
slight forcing at the most. This approach was adopted because the
porcine ascending aorta was extremely elastic, a feature that might
have introduced a bias into prosthesis size selection. Indeed, over-
sizing was theoretically possible in the case of all valves, owing to
the extreme elasticity of the aortic root wall; in real life, however,
the stiffness of the aorta would have made this difﬁcult, if not
impossible. The probes that ﬁtted for TRI and MG had the label
size of 21, and the valve replica of both seemed to ﬁt perfectly
(neither too big nor too small); thus, a size 21 was selected for
both. The sizing strategy for the MF was undertaken with the valve
replica alone, as this is the only tool provided by the manufacture;
a labelled size 23 was chosen, as this ﬁtted well. These three valves
— TRI, MG and MF—have the same ED, which is 2.6 cm. With
regard to the SA, the decision was not so straightforward; even
though the probe for the size labelled 22 was able to get through
the native annulus, the valve replica appeared too bulky to use. A
size 20 was therefore chosen. Nevertheless, this had to be forced
slightly, as its ED is 28 mm.
The aortic root samples were then harvested by two experi-
enced surgeons. The samples included 1.5 cm of the left ventricu-
lar outﬂow tract, which was rendered cylindrical by closing the
mitral valve commissures with a running suture to the adjacent
muscular septum. The ascending aorta was transected 0.5 cm
above the sinotubular junction and the coronary ostia were
ligated to prevent ﬂuid loss. Circular Dacron meshes were sutured
to the inﬂow and outﬂow of the aortic root sample, in order to ﬁx
it into the housing section of the mock loop, as previously
described [14–16].
Experimental design
Tests simulating physiological conditions for patients at rest were
conducted on the mock loop. The stroke volume (SV) imposed by
the pulsatile pump was set at 65 ml, similar to the basal value in
patients with a native aortic annulus of 2.1 cm. The systolic ejec-
tion time was set at one-third of the entire cardiac cycle, and the
heart rate at 70 bpm, with a mean simulated arterial pressure of
80–104 mmHg.
After being excised and housed in the test-section holder of
the mock loop, each of the eight fresh porcine aortic root samples
was ﬁrst tested untreated (basal condition). The four bioprostheses
were then successively implanted in each sample in a randomized
sequence. Each prosthesis was tested and then carefully removed
from the aortic root; this led to a total of 40 experimental points
(eight aortic roots per four bioprostheses, plus eight experimental
points in basal conditions). For each point, experimental data
were evaluated over ﬁve consecutive simulated heart cycles.
The prostheses were implanted by means of a simple inter-
rupted suture technique with Ethibond 2/0. After each implant-
ation, and prior to testing in the mock loop, the prostheses
were visually inspected via the digital video, in order to qualita-
tively assess their integrity and proper functioning. No prosthesis
needed to be discarded during the entire experiment.
The ﬂow rate, the pressures upstream and downstream of the
aortic root and the pressure in the afterload were acquired at a sam-
pling rate of 200 Hz via an A/D acquisition board. Post-processing of
the raw data was performed to calculate the following quantities:
(i) The mean systolic pressure drop (Δpm, mmHg) across the aortic
root unit as shown in Fig. 1, as the difference between pressures
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(ii) The maximum systolic pressure drop (Δpm, mmHg).
(iii) The effective oriﬁce area (EOA) cm2, calculated from the fol-
lowing formula:





where Qrms (l/min) is the square root of the mean systolic
ﬂow rate, Δpm (mmHg) the mean systolic pressure drop
across the sample and k a conversion factor (k = 3.1 to yield
the EOA in cm2).
(iv) Performance index (Pi) = EOA/IA. IA stands for the internal
area, calculated from the ID values provided by the manu-
facturers as TRI = 1.83 cm, MF = 1.9 cm, SA = 1.98 cm and
MG = 2.0 cm.
(v) Valve resistance (VR) = 1333*Δpm/mean ﬂow (ml/s), where Δp
mean is the pressure drop across the valve.
(vi) Systolic energy loss (%): the percentage of the energy
provided by the pump that is lost when the ﬂuid passes
through the prosthesis.
Statistical analysis
Continuous variables were expressed as mean values ± standard
deviation (SD) and compared by analysis of variance for repeated
measures; in the graphic, the values were reported with 95% of
conﬁdence intervals; P-values < 0.05 were considered signiﬁcant.
Post hoc analysis was done by applying the Bonferroni test. The
data were analysed by means of the StatSoft 8.2 software.
RESULTS
No valve displayed any signiﬁcant structural problems in any of
the test sessions. Table 1 reports the results of the study; no differ-
ences were found in SV or mean ﬂow through the valves. As
expected, the ﬂuid-dynamic performance of all the prostheses
was inferior to that of a normal aortic valve with regard to all the
parameters considered (Table 1 and Fig. 2). On comparing the
prostheses, the EOAs were 2.3 ± 0.3, 1.75 ± 0.2, 1.57 ± 0.2 and
1.77 ± 0.2 cm2 (P = 0.001) for TRI, SA, MG and MF, respectively.
The mean gradients behaved accordingly, being 6.1 ± 2, 9.6 ± 3,
13.2 ± 3 and 10.2 ± 3 mmHg (P = 0.001) for TRI, SA, MG and MF,
respectively. Table 1 and Figure 2 also show a statistically signiﬁ-
cant difference between MF and MG and between SA and MG
(P < 0.01 and P < 0.01, respectively). Energy loss and resistance
were better in TRI than in the other prostheses, the differences
being statistically signiﬁcant.
DISCUSSION
This study conﬁrmed that implanted stented prostheses are inher-
ently obstructive, in that all the parameters considered revealed
poorer haemodynamic performance than that of the native valve
(Table 1). This is due to several reasons: ID dimension, the stiffness
of the mounting stent, the nature of the leaﬂets and their stiffness,
the position where the pericardium is mounted (i.e. inside or
outside the stent) and the ‘annulus-prosthesis’ interaction.
As high residual gradients and patient-prosthesis mismatch have
been associated to worse early and long-term outcomes [3–5], the
performance of the prosthesis cannot be neglected. Pericardial
stented valves have a better ﬂuid-dynamic performance than por-
cine valves, and these differences are more pronounced in patients
with a smaller aortic annulus [8, 9].
However, performance alone is not the only aspect to consider.
To meet the patient’s haemodynamic requirements, the sizing of
the stented valve and the anatomy of the aortic root appear to
have an important role in selecting the dimensions of prostheses
[13]. In this regard, Doenst et al. showed that postoperative
haemodynamic results can be inﬂuenced by the sizing strategy
indicated by the manufacturer, and Ruzicka et al. [11] reported
that, even in patients with native annuli of the same size, it is not
always possible to implant the same size of prosthesis of the same
brand. In addition, a role might also be played by the suture tech-
nique used to implant the prosthesis [17]. Thus, the haemodynam-
ic results stem not only from the efﬁciency of the prosthesis but
also from a process that involves the manufacturer’s sizing strategy,
the aim of which is to help the surgeon to implant the valve com-
fortably, and the surgeon’s own ‘strategy’, the aim of which is to
implant a valve that best ﬁts the patient’s haemodynamic require-
ments. The surgeon’s strategy requires experience and knowledge
of the dimensions of the bioprostheses of each brand, as the ID
and encumbrance (i.e. TAD and ED) differ from one prosthesis to
another.
Interpretation of in vitro study results
All the prostheses examined in this study yielded excellent ﬂuid-
dynamic performance, with low gradients and consistent EOAs.
Figure 1: (A) The mock loop scheme and (B) a prosthesis implanted in the ARFU (aortic root functional unit) housed in the holder.
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Table 1: Fluid-dynamic results
MG MF TRI SA Native valve P-value
SV (ml) 68 ± 4 66 ± 4 67 ± 4 65 ± 7 69 ± 3 0.543
Mean flow (ml/s) 252 ± 11 247 ± 13 247 ± 12 246 ± 22 251 ± 9 0.824
Mean gradient (mmHg) 13.2 ± 3a,b.c.d 10.2 ± 3e,f 6.1 ± 2g,h 9.6 ± 3i 2 ± 0.3 <0.001
Peak gradient (mmHg) 30 ± 4a,b,c,d 25 ± 4f,l 21 ± 3h 24 ± 2i 16 ± 1 <0.001
EOA (cm2) 1.57 ± 0.2b,d 1.77 ± 0.2e,f 2.31 ± 0.3g,h 1.75 ± 0.2i 4 ± 0.4 <0.001
Performance index 0.50 ± 0.06a,b 0.63 ± 0.08e 0.89 ± 0.13g 0.56 ± 0.07 na <0.001
Mean systolic Pr (mmHg) 87 ± 6m 89 ± 14 87 ± 7n 80 ± 13i 104 ± 15 <0.001
Valve resistance (dyn*s/cm5) 69 ± 16a,b,c,d 55 ± 13e,f 33 ± 10g,h 51 ± 11i 10 ± 2 <0.001
En loss (%) 13.5 ± 0.5a,b,c,d 10.7 ± 2.5e,f 6.6 ± 1.6g,h 10.9 ± 1.8i 2.1 ± 0.5 <0.001
aMG vs MF P < 0.01.
bMG vs TRI P < 0.01.
cMG vs SA P < 0.01.
dMG vs Native P < 0.01.
eMF vs TRI P < 0.01.
fMF vs Native P < 0.01.
gTRI vs SA P < 0.01.
hTRI vs Native P < 0.01.
iSA vs Native P < 0.01.
lMF vs TRI P = 0.04.
mMG vs Native P = 0.02.
nTRI vs Native P = 0.02.
MG: Magna Ease; MF: Mitroflow; TRI: Trifecta; SA: Soprano-Armonia; SV: stroke volume; EOA: effective orifice area.
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The performance of the TRI, however, proved to be better than that
of the other prostheses studied with on average, an EOA larger than
that of the other valves, and the mean gradients behaved accord-
ingly (Table 1 and Fig. 2). These results cannot be directly compared
with those from other in vitro studies because we tested prostheses
that were surgically implanted. However, with regard to in vitro
results for MF, MG and SA, in terms of both EOAs and mean gradi-
ents, our results were consistent with those reported by other
authors [12]. Our data are also in line with those reported in clinical
study by Ugur et al. [18] and Wendt et al. [19] in which the TRI 21
size showed lower gradients, larger EOAs and lower incidence of
patient-prosthesis mismatch thanMF 23 and/or MG 21 sizes.
Durability is the most important characteristic required of a bio-
prosthesis and the small differences, in mean gradients, we found
in our study are unlikely to have a clinical impact in the population
of patients in which these prostheses are usually implanted.
The transvalvular gradient is mainly dependent on both SV and
EOA [20]. The EOA is related to the GOA, which is, in turn, related
both to the ID of the prosthesis and to the impedance of the leaf-
lets, as they may reduce the area made available by the size of the
inner ring. This is conﬁrmed by our study, as reported in Table 1
and Fig. 2. Indeed, TRI, whose pericardial sheet is outside the
stent, had the smallest ID but provided the largest EOA, with a Pi
of 0.89 ± 0.13; this means that the internal area was almost com-
pletely available to the ﬂow. MF displayed a similar trend; its Pi
of 0.63 ± 0.08 being better than those of both MGs 0.50 ± 0.06
(P = 0.01) and SAs 0.56 ± 0.07, though in the case of this latter
prosthesis, the difference did not reach statistical signiﬁcance
(P = 0.133). When the pericardial sheet is outside the stent, the
stent itself must be thin; thus, we cannot exclude the possibility
that the commissures are pushed outward during systole, thereby
contributing to this large EOA. With such a Pi, it is plausible that
the haemodynamic performance of TRI is close to that of a stent-
less valve, as recently shown during stress testing [21] and in a ran-
domized study in patients with a small aortic annulus [22]. In the
latter study, it was found that, in patients with an average native
annulus of 2.1 ± 0.1 cm, the mean gradient on discharge was as
low as 5.5 ± 3 mmHg for TRI vs 7.5 ± 4 for Freestyle, with a P-value
close to signiﬁcance (P = 0.06).
In our study, we combined the haemodynamic reproducibility
of the in vitro setting with the speciﬁcity of surgery by surgically
implanting prostheses in a porcine aortic root. We were able to
make a fair comparison among the four stented pericardial pros-
theses, as each prosthesis was implanted in the same anatomical
conditions, following standardized sizing in order to avoid the
biases of the manufacturers’ sizing strategy. It is interesting to note
how the aortic root-prosthesis interaction inﬂuenced the mean
gradients, the SD of the mean gradient of the native valve being
5- to 10-fold smaller than the SD of the mean gradients of the
prostheses. This conﬁrms that the haemodynamic results differ
according to the aortic root in which the bioprosthesis is
implanted. Thus, comparisons of haemodynamic performance
among prostheses of different brands in clinical studies are in-
accurate, and the only way to obtain fairly reliable data on per-
formance is to make comparisons on the basis of the actual native
annulus diameter that the different bioprostheses ﬁt.
Conclusion
The present study showed that prostheses with the pericardium
housed outside the stent were more efﬁcient, and that TRI displayed
better haemodynamics than the other prostheses. This study also
highlights how difﬁcult it is to compare different types of prostheses
in clinical studies and the fact that comparison has to be made at
least by taking into account the native aortic annulus size. The role
of the surgeon and the sizing strategy adopted appear to be very
important in exploiting, or failing to exploit, the haemodynamic
characteristics of the prosthesis.
Study limitations
Even though in this study all the conditions to which the pros-
theses were exposed were equal, the implantability characteristics
of each bioprosthesis along with the surgeon level of experience
in implanting a speciﬁc type of prosthesis might have inﬂuen-
ced the results. However, these are biases difﬁcult to neutralize
because they are speciﬁc to the surgical act.
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